|
|
Intermediate manufacturers
face an growing need to have a clear picture of the emerging
chemical opportunities that exist within the life-cycle of
a pharmaceutical. In-depth information on the development of pharmaceuticals and the ability
to track the progress of these drugs will significantly reduce
the risk of losing out. In addition to monitoring the performance
of new emerging pharmaceuticals, it is essential to monitor
existing markets to identify areas that are expanding or decreasing
and react accordingly. By using quantitative data on sales
within countries, companies and molecules, growing markets
can be identified, the effects of a patent expiry tracked
and regional sales monitored.
To complete the picture, the capability to uncover licensing opportunities for products and assess the
strengths of potential export opportunities in relevant markets
enables companies to remain competitive.
|
